Companies

Faruqi & Faruqi, LLP Examines Investor Claims Against QuidelOrtho Corporation QDEL

Published May 31, 2024

NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a prestigious securities law firm with national reach, has announced an investigation into potential claims on behalf of investors of QuidelOrtho Corporation QDEL ("QuidelOrtho" or the "Company"). QuidelOrtho is a leading diagnostic healthcare manufacturer specializing in a broad range of sectors ranging from infectious disease to toxicology. With a growing global presence, the company’s innovative solutions are critical in promoting health and wellbeing. Headquartered in San Diego, California, QuidelOrtho continues to make significant strides in the healthcare industry.

Potential Investor Claims Under Investigation

With the forthcoming June 11, 2024, the deadline for investors to seek a lead plaintiff position, Faruqi & Faruqi, LLP is urging shareholders of QuidelOrtho to come forward with any claims they may have against the company. The firm is investigating potential breaches of fiduciary duty and other violations of law by the Company’s management team or board of directors. QuidelOrtho's commitment to healthcare advancement is noteworthy, and the outcome of these investigations could be significant for both the company and its investors.

Deadline for Investors Fast Approaching

Investors who have suffered losses and believe that QuidelOrtho may have misled shareholders are encouraged to contact Faruqi & Faruqi, LLP ahead of the June 11, 2024, the deadline to discuss their legal rights. The firm represents a history of enacting change and enforcing corporate governance standards, which may be a beacon of accountability for entities like QuidelOrtho. As the date approaches, investors’ decisions to engage with Faruqi & Faruqi, LLP could have a long-lasting impact on the integrity and performance of QuidelOrtho QDEL.

Faruqi, Investigation, QuidelOrtho, Claim, Deadline, Lawfirm, Shareholders, Securities, Healthcare, Diagnostic, Financial, Legal, Corporate, Governance, Investors, Accountability